Target intelligence / Profile preview

Influenza A virus hemagglutinin head trimer interface epitope (HA head trimer interface)

Target
HA head trimer interface
Molecular classification
Viral surface glycoprotein, Class I viral fusion protein, Antigenic epitope
01

Overview

The Influenza A virus hemagglutinin (HA) head trimer interface epitope is a highly conserved site located within the globular head domain of the HA protein, which is typically occluded in the native, pre-fusion trimeric conformation. Unlike the immunodominant head regions that undergo rapid antigenic drift, the residues at the trimer interface are relatively stable across diverse influenza strains, making them an attractive target for broadly neutralizing antibodies (bnAbs). These antibodies, such as FluA-20, function by recognizing the epitope when the HA head domains transiently 'breathe' or dissociate, subsequently preventing the structural rearrangements necessary for viral-host membrane fusion. By targeting this hidden site, therapeutics can achieve cross-reactivity against multiple subtypes of Influenza A, including both Group 1 and Group 2 viruses. This epitope represents a significant shift in vaccine and monoclonal antibody design, moving away from the highly variable receptor-binding site toward more conserved, functionally critical structural regions of the virus.

Other names
HA head interfaceHemagglutinin trimer interface epitopeOccluded HA head epitopeInfluenza A HA head interfaceHA1-HA1 interface
02

Mechanism of action

Antibodies targeting this epitope bind to the normally occluded interface between the globular head domains of the hemagglutinin trimer, leading to trimer dissociation or preventing the conformational changes required for viral membrane fusion and entry into the host cell.

03

Biological functions

Viral attachmentMembrane fusionReceptor bindingViral entryTrimer stabilization
04

Disease associations

InfectionInfluenza ARespiratory tract infection
05

Safety considerations

Viral escape mutationsAntibody-dependent enhancement (ADE) (theoretical)Limited accessibility of the epitope in native trimeric stateStrain-specific variability in interface residues
06

Interacting drugs

FluA-20

4 more in the full profile.

07

Biomarkers

Hemagglutinin inhibition (HAI) titerMicroneutralization assayViral load (Influenza A RNA)Anti-HA head interface antibody serum levels

Beyond the preview

Go deeper on Influenza A virus hemagglutinin head trimer interface epitope (HA head trimer interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus hemagglutinin head trimer interface epitope (HA head trimer interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call